Olivereau M, Olivereau JM, Lambert JF. In vivo effect of dopamine antagonists on melanocyte-stimulating hormone cells of the goldfish (Carassius auratus L.) pituitary.
Gen Comp Endocrinol 1987;
68:12-8. [PMID:
3666418 DOI:
10.1016/0016-6480(87)90054-2]
[Citation(s) in RCA: 15] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Abstract
Young goldfish were injected with three dopaminergic antagonists, pimozide, sulpiride, and domperidone, for 5 (low dose) and 7 days (higher dose). Cytological and immunocytochemical techniques using anti-alpha-melanocyte-stimulating hormone (MSH) serum were applied to the pituitary. MSH cells in the three treated groups showed a decrease in immunoreactive cytoplasmic granules, a significant nuclear hypertrophy, and, after 7 days, a cellular enlargement. The nucleolus and the lamellar endoplasmic reticulum were more developed and some mitotic figures occurred. Erythrophores and occasional melanophores were in a stage of maximal dispersion. These changes were not apparent in the solvent-injected controls. The responses to the three blockers of dopaminergic receptors were similar. These data suggest that MSH release seems to be under a dopaminergic inhibitory control in the goldfish. The other cell type of the pars intermedia (PAS-positive and calcium-sensitive in the goldfish) was not clearly affected by the three drugs.
Collapse